Rapid modulation of μ-opioid receptor signaling in primary sensory neurons

Journal of Pharmacology and Experimental Therapeutics

Volumn 321, Issue 3, 2007, Pages 839-847

  Berg, Kelly A ^a   Patwardhan, Amol M ^b   Sanchez, Teresa A ^a   Silva, Yamille M ^a   Hargreaves, Kenneth M ^a,b   Clarke, William P ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; ARACHIDONIC ACID; BRADYKININ; ENKEPHALIN[2 DEXTRO ALANINE 4 METHYLPHENYLALANINE 5 GLYCINE]; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); ICATIBANT; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR AGONIST; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; SERYLLEUCYLISOLEUCYLGLYCYLARGINYLLEUCINE AMINE AFFECTING AGENT; UNCLASSIFIED DRUG; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRADYKININ B2 RECEPTOR; CALCITONIN GENE RELATED PEPTIDE; CAPSAICIN; CYCLIC AMP; ENZYME INHIBITOR; INOSITOL PHOSPHATE; PHORBOL DIBUTYRATE; PHOSPHOLIPASE C; PROTEINASE ACTIVATED RECEPTOR 2;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG BINDING; DRUG EFFECT; DRUG INHIBITION; ENZYME ACTIVITY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SENSORY NERVE CELL; TRIGEMINUS GANGLION; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; DRUG POTENTIATION; GENE EXPRESSION; GENETICS; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ADENYLATE CYCLASE; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; ARACHIDONIC ACID; BRADYKININ; CALCITONIN GENE-RELATED PEPTIDE; CAPSAICIN; CELLS, CULTURED; CYCLIC AMP; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; ENKEPHALIN, ALA(2)-MEPHE(4)-GLY(5)-; ENZYME INHIBITORS; GENE EXPRESSION; INOSITOL PHOSPHATES; MALE; NEURONS, AFFERENT; PHORBOL 12,13-DIBUTYRATE; PHOSPHOLIPASE C; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, BRADYKININ B2; RECEPTOR, PAR-2; RECEPTORS, OPIOID, MU; SIGNAL TRANSDUCTION;

EID: 34248525078     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.106.116681     Document Type: Article

References (52)

1. Allen MR, Zhang BR, Hettinger AM, Goad DW, Malayer JR, and Geisert RD (2002) Detection of bradykinin and bradykinin-beta(2) receptors in the porcine endometrium during the estrous cycle and early pregnancy. Biol Reprod 66:574-579.
2. Arvidsson U, Riedl M, Chakrabarti S, Lee JH, Nakano AH, Dado RJ, Loh HH, Law PY, Wessendorf MW, and Elde R (1995) Distribution and targeting of a mu-opioid receptor (MOR1) in brain and spinal cord. J Neurosci 15:3328-3341.
3. Atanassoff PG, Brull SJ, Printsev Y, and Silverman DG (1997) The effect of intradermal administration of lidocaine and morphine on the response to thermal stimulation. Anesth Analg 84:1340-1343.
4. Bailey CP, Kelly E, and Henderson G (2004) Protein kinase C activation enhances morphine-induced rapid desensitization of mu-opioid receptors in mature rat locus ceruleus neurons. Mol Pharmacol 66:1592-1598.
5. Berg KA, Maayani S, Goldfarb J, Scaramellini C, Leff P, and Clarke WP (1998) Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: evidence for agonist-directed trafficking of receptor stimulus. Mol Pharmacol 54:94-104.
6. Bhattacharya M, Peri K, Ribeiro-da-Silva A, Almazan G, Shichi H, Hou X, Varma DR, and Chemtob S (1999) Localization of functional prostaglandin E2 receptors EP3 and EP4 in the nuclear envelope. J Biol Chem 274:15719-15724.
7. Bohn LM, Lefkowitz RJ, and Caron MG (2002) Differential mechanisms of morphine antinociceptive tolerance revealed in (beta)arrestin-2 knock-out mice. J Neurosci 22:10494-10500.
8. Borgland SL, Connor M, Osborne PB, Furness JB, and Christie MJ (2003) Opioid agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opioid receptors. J Biol Chem 278:18776-18784.
9. Chan JS, Chiu TT, and Wong YH (1995) Activation of type II adenylyl cyclase by the cloned mu-opioid receptor: coupling to multiple G proteins. J Neurochem 65:2682-2689.
10. Chen JJ, Dymshitz J, and Vasko MR (1997) Regulation of opioid receptors in rat sensory neurons in culture. Mol Pharmacol 51:666-673.
11. Connor M and Christie MJ (1999) Opioid receptor signaling mechanisms. Clin Exp Pharmacol Physiol 26:493-499.
12. Dionne RA, Lepinski AM, Gordon SM, Jaber L, Brahim JS, and Hargreaves KM (2001) Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation. Clin Pharmacol Ther 70:66-73.
13. Evans KL, Cropper JD, Berg KA, and Clarke WP (2001) Mechanisms of regulation of agonist efficacy at the 5-HT1A receptor by phospholipid-derived signaling components. J Pharmacol Exp Ther 297:1025-1035.
14. Ferreira SH and Nakamura M (1979) II - Prostaglandin hyperalgesia: the peripheral analgesic activity of morphine, enkephalins and opioid antagonists. Prostaglandins 18:191-200.
15. Folco G and Murphy RC (2006) Eicosanoid transcellular biosynthesis: from cell-cell interactions to in vivo tissue responses. Pharmacol Rev 58:375-388.
16. Gibbs JL, Diogenes A, and Hargreaves KM (2007) Neuropeptide Y modulates effects of bradykinin and prostaglandin E2 on trigeminal nociceptors via activation of the Y1 and Y2 receptors. Br J Pharmacol 150:72-79.
17. Gobeil F Jr, Dumont I, Marrache AM, Vazquez-Tello A, Bernier SG, Abran D, Hou X, Beauchamp MH, Quiniou C, Bouayad A, et al. (2002) Regulation of eNOS expression in brain endothelial cells by perinuclear EP(3) receptors. Circ Res 90:682-689.
18. Gupta A, Axelsson K, Allvin R, Liszka-Hackzell J, Rawal N, Althoff B, and Augustini BG (1999) Postoperative pain following knee arthroscopy: the effects of intra-articular ketorolac and/or morphine. Reg Anesth Pain Med 24:225-230.
19. Gupta A, Bjornsson A, Sjoberg F, and Bengtsson M (1993) Lack of peripheral analgesic effect of low-dose morphine during intravenous regional anesthesia. Reg Anesth 18:250-253.
20. Gupta A, Bodin L, Holmstrom B, and Berggren L (2001) A systematic review of the peripheral analgesic effects of intraarticular morphine. Anesth Analg 93:761-770.
21. Inoue M and Ueda H (2000) Protein kinase C-mediated acute tolerance to peripheral mu-opioid analgesia in the bradykinin-nociception test in mice. J Pharmacol Exp Ther 293:662-669.
22. Jabbour HN and Sales KJ (2004) Prostaglandin receptor signalling and function in human endometrial pathology. Trends Endocrinol Metab 15:398-404.
23. Jenkins DW, Sellers LA, Feniuk W, and Humphrey PP (2003) Characterization of bradykinin-induced prostaglandin E2 release from cultured rat trigeminal ganglion neurones. Eur J Pharmacol 469:29-36.
24. Jeske NA, Patwardhan AM, Gamper N, Price TJ, Akopian AN, and Hargreaves KM (2006) Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons. J Biol Chem 281:32879-32890.
25. Ji RR, Zhang Q, Law PY, Low HH, Elde R, and Hokfelt T (1995) Expression of mu-, delta-, and kappa-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J Neurosci 15:8156-8166.
26. Joris JL, Dubner R, and Hargreaves KM (1987) Opioid analgesia at peripheral sites: a target for opioids released during stress and inflammation. Anesth Analg 66:1277-1281.
27. Kinnman E, Nygards EB, and Hansson P (1997) Peripherally administrated morphine attenuates capsaicin-induced mechanical hypersensitivity in humans. Anesth Analg 84:595-599.
28. Ko MC, Tuchman JE, Johnson MD, Wiesenauer K, and Woods JH (2000) Local administration of mu or kappa opioid agonists attenuates capsaicin-induced thermal hyperalgesia via peripheral opioid receptors in rats. Psychopharmacology 148:180-185.
29. Lal MA, Proulx PR, and Hebert RL (1998) A role for PKC epsilon and MAP kinase in bradykinin-induced arachidonic acid release in rabbit CCD cells. Am J Physiol 274:F728-F735.
30. Law PY, Wong YH, and Loh HH (2000) Molecular mechanisms and regulation of opioid receptor signaling. Annu Rev Pharmacol Toxicol 40:389-430.
31. Leeb-Lundberg LM, Marceau F, Muller-Esterl W, Pettibone DJ, and Zuraw BL (2005) International Union of Pharmacology: XLV. classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57:27-77.
32. Leslie CC (2004) Regulation of the specific release of arachidonic acid by cytosolic phospholipase A2. Prostaglandins Leukot Essent Fatty Acids 70:373-376.
33. Levine JD and Taiwo YO (1989) Involvement of the mu-opiate receptor in peripheral analgesia. Neuroscience 32:571-575.
34. Li JL, Ding YQ, Li YQ, Li JS, Nomura S, Kaneko T, and Mizuno N (1998) Immunocytochemical localization of mu-opioid receptor in primary afferent neurons containing substance P or calcitonin gene-related peptide: a light and electron microscope study in the rat. Brain Res 794:347-352.
35. Likar R, Koppert W, Blatnig H, Chiari F, Sittl R, Stein C, and Schafer M (2001) Efficacy of peripheral morphine analgesia in inflamed, non-inflamed and perineural tissue of dental surgery patients. J Pain Symptom Manage 21:330-337.
36. Makman MH, Dvorkin B, and Crain SM (1988) Modulation of adenylate cyclase activity of mouse spinal cord-ganglion explants by opioids, serotonin and pertussis toxin. Brain Res 445:303-313.
37. Mukhin YV, Garnovsky EA, Ullian ME, and Garnovskaya MN (2003) Bradykinin B2 receptor activates extracellular signal-regulated protein kinase in mIMCD-3 cells via epidermal growth factor receptor transactivation. J Pharmacol Exp Ther 304:968-977.
38. Olianas MC and Onali P (1995) Participation of delta opioid receptor subtypes in the stimulation of adenylyl cyclase activity in rat olfactory bulb. J Pharmacol Exp Ther 275:1560-1567.
39. Patwardhan A, Berg K, Akopian A, Jeske N, Gamper N, Clarke W, and Hargreaves K (2005) Bradykinin induces functional competence and trafficking of the Delta opioid receptor in trigeminal nociceptors. J Neurosci 25:8825-8832.
40. Patwardhan AM, Diogenes A, Berg KA, Fehrenbacher JC, Clarke WP, Akopian AN, and Hargreaves KM (2006) PAR-2 agonists activate trigeminal nociceptors and induce functional competence in the delta opioid receptor. Pain 125:114-124.
41. Sales KJ, Maudsley S, and Jabbour HN (2004) Elevated prostaglandin EP2 receptor in endometrial adenocarcinoma cells promotes vascular endothelial growth factor expression via cyclic 3′,5′-adenosine monophosphate-mediated transactivation of the epidermal growth factor receptor and extracellular signal-regulated kinase 1/2 signaling pathways. Mol Endocrinol 18:1533-1545.
42. Sarlani E, Balciunas BA, and Grace EG (2005) Orofacial pain - part I: assessment and management of musculoskeletal and neuropathic causes. AACN Clin Issues 16:333-346.
43. Shears SB (1991) Regulation of the metabolism of 1,2-diacylglycerols and inositol phosphates that respond to receptor activation. Pharmacol Ther 49:79-104.
44. Shin CY, Shin J, Kim BM, Wang MH, Jang JH, Surh YJ, and Oh U (2003) Essential role of mitochondrial permeability transition in vanilloid receptor 1-dependent cell death of sensory neurons. Mol Cell Neurosci 24:57-68.
45. Stein C, Schafer M, and Machelska H (2003) Attacking pain at its source: new perspectives on opioids. Nat Med 9:1003-1008.
46. Trejo J (2003) Protease-activated receptors: new concepts in regulation of G protein-coupled receptor signaling and trafficking. J Pharmacol Exp Ther 307:437-442.
47. Ueda H, Inoue M, and Matsumoto T (2001) Protein kinase C-mediated inhibition of mu-opioid receptor internalization and its involvement in the development of acute tolerance to peripheral mu-agonist analgesia. J Neurosci 21:2967-2973.
48. Uhle RA, Reader A, Nist R, Weaver J, Beck M, and Meyers WJ (1997) Peripheral opioid analgesia in teeth with symptomatic inflamed pulps. Anesth Prog 44:90-95.
49. Vaughan CW, Ingram SL, Connor MA, and Christie MJ (1997) How opioids inhibit GABA-mediated neurotransmission. Nature (Lond) 390:611-614.
50. Welch K (2001) Headache, Lippincott, Williams and Wilkins, Philadelphia, PA.
51. Wrench IJ, Girling KJ, and Hobbs GJ (1996) Alfentanil-mediated analgesia during propofol injection: no evidence for a peripheral action. Br J Anaesth 77:162-164.
52. Zollner C, Shaqura MA, Bopaiah CP, Mousa S, Stein C, and Schafer M (2003) Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol Pharmacol 64:202-210.